Burkhard Zoller Named Chief Financial Officer Of Evonik Corporation
Evonik Corporation, a subsidiary of specialty chemical company Evonik Industries AG, has appointed Burkhard Zoller as chief financial officer for North America, effective Jan. 1, 2014.
Zoller, currently head of Evonik’s Inorganic Materials Business Unit for North America, will report to Evonik North America Region President John Rolando and succeeds Roger Avery, who is retiring after 36 years at the company.
“I am pleased Burkhard has accepted this important position in North America, particularly with his extensive experience in a variety of finance and business leadership roles within Evonik around the world,” Rolando said. “I welcome Burkhard to my regional leadership team as we continue to explore growth opportunities. I would also like to recognize Roger Avery for his many years of leadership and contributions to Evonik’s success. We wish him all the best in his retirement.”
Zoller has served in his current position since June 2010 and was previously global head of controlling and business services for Evonik’s Performance Polymers Business Unit. After completing his chemical engineering studies, Zoller joined the company in 1985 as a plant engineer. He held various positions in Germany and led an investment project in Korea before joining MEMC, a silicon wafer manufacturer, in 1995 and working in the United States for five years.
Among other positions, Zoller worked in capital planning and, as finance director, was responsible for MEMC's operations in Asia. Zoller returned to Germany in 2000 to work in strategic projects until he was appointed head of Business Unit controlling within Performance Polymers in 2003.
For additional information about Evonik in North America, please visit our website: www.evonik.com/north-america. Please visit us on Facebook at www.facebook.com/EvonikNorthAmerica. Follow us on Twitter at http://twitter.com/EvonikN_America.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.4 billion and an operating profit (adjusted EBITDA) of about €2.4 billion (excluding Real Estate in both cases).
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.